Single-dose pharmacokinetics of delavirdine mesylate and didanosine in patients with human immunodeficiency virus infection.

Delavirdine is a nonnucleoside reverse transcriptase inhibitor with in vitro activity against human immunodeficiency virus type 1 (HIV-1) that is currently being evaluated in combination regimens with various nucleoside analogs, including didanosine. Due to the pH-dependent solubility of delavirdine...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Morse, G D, Fischl, M A, Shelton, M J, Cox, S R, Driver, M, DeRemer, M, Freimuth, W W
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1997
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163679/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8980774/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.1.169
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!